John Xu
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
-
- Diabetes Treatment and Management
- Diabetes Management and Research
Papers in
-
- Diabetes Treatment and Management 12
- Diabetes Management and Research 4
- Surgery 6
- Pancreatic function and diabetes 5
- Co-authors
- Tom Mikkelsen (1 shared paper)Juliane M. Jürgensmeier (1 shared paper)John DeGroot (1 shared paper)Mario Campone (1 shared paper)Mark Rosenthal (1 shared paper)Paresh Dandona (9 shared papers)Franz Payer (1 shared paper)Burt Nabors (1 shared paper)
- Journals
- Diabetes Obesity and Metabolism (4 papers)Diabetes (3 papers)Investigational New Drugs (2 papers)Journal of Clinical Oncology (2 papers)Therapeutic Advances in Respiratory Disease (1 paper)
- Partner nations
- United StatesSwedenGermany
In The Last Decade
John Xu
24 papers receiving 997 citations
John Xu's Hit Papers
Peers
Comparison fields: 5 of 67
- Genetics 318
- Endocrinology, Diabetes and Metabolism 353
- Cancer Research 118
- Nephrology 39
- Pulmonary and Respiratory Medicine 135
Countries citing papers authored by John Xu
This map shows the geographic impact of John Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Xu more than expected).
Fields of papers citing papers by John Xu
This network shows the impact of papers produced by John Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Xu. The network helps show where John Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside John Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma Hit paper breakdown → | 2013 | 444 |
| 2 | 2017 | 116 | |
| 3 | 2020 | 57 | |
| 4 | 2016 | 40 | |
| 5 | 2017 | 36 | |
| 6 | 2019 | 35 | |
| 7 | 2020 | 35 | |
| 8 | 2013 | 34 | |
| 9 | 2017 | 32 | |
| 10 | 2016 | 29 | |
| 11 | 2017 | 28 | |
| 12 | 2020 | 27 | |
| 13 | 2020 | 25 | |
| 14 | 2005 | 23 | |
| 15 | 2010 | 18 | |
| 16 | 2018 | 10 | |
| 17 | 2019 | 8 | |
| 18 | 2007 | 7 | |
| 19 | 2014 | 4 | |
| 20 | 2024 | 4 |
About John Xu
John Xu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, having authored 27 papers that have together received 1.0k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (12 papers), Pancreatic function and diabetes (5 papers), Diabetes Management and Research (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Cancer Treatment and Pharmacology (2 papers), Asthma and respiratory diseases (2 papers), Systemic Sclerosis and Related Diseases (1 paper) and Inhalation and Respiratory Drug Delivery (1 paper). The work is most often cited by research in Genetics (318 citations), Endocrinology, Diabetes and Metabolism (353 citations), Cancer Research (118 citations), Nephrology (39 citations) and Pulmonary and Respiratory Medicine (135 citations). John Xu has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include Tom Mikkelsen, Juliane M. Jürgensmeier, John DeGroot, Mario Campone, Mark Rosenthal, Paresh Dandona, Franz Payer, Burt Nabors, Lawrence Cher and A. Gregory Sorensen. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes, Investigational New Drugs, Journal of Clinical Oncology and Therapeutic Advances in Respiratory Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.